Showing results (161-170 of 189) with videos related to

Sort By:
Pageof 19
Cancer Treatment and Research Communications|April 27, 2021
RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysisS Ponce Aix, S Novello, E B Garon, et al.
Revue Des Maladies Respiratoires|February 22, 2008
[How to treat the relapse of NSCLC after surgery and chemotherapy? IFTC 0702 randomized phase III study]D Moro-Sibilot, F Barlesi, J F Timsit, et al.
Techniques in Coloproctology|September 25, 2025
Comparing the effectiveness of prophylactic strategies for parastomal hernia prevention: a network meta-analysisJ Martín-Arévalo, V A López-Callejon, D Moro-Valdezate, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy for non-small-cell lung cancerE Quoix, B Lebeau, A Depierre, et al.
Clinical Practice and Epidemiology in Mental Health : CP & EMH|December 15, 2017
Risk for Depression, Burnout and Low Quality of Life Among Personnel of a University Hospital in Italy is a Consequence of the Impact One Economic Crisis in the Welfare System?M G Carta, A Preti, I Portoghese, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2010
Inter- and intraobserver consistency in assessing eligibility for bevacizumab (BVZ) in non-small-cell lung cancer (NSCLC) patients with centrally located tumorsF Barlési, C Balleyguier, B Besse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2015
High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targetsV Fallet, R Saffroy, N Girard, et al.
Respiratory Medicine and Research|June 22, 2020
Proposals for managing patients with thoracic malignancies during COVID-19 pandemicN Girard, L Greillier, G Zalcman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
Long-term survivors of small-cell lung cancer (SCLC): a French multicenter study. Groupe d'Oncologie de Langue FrançaiseP Jacoulet, A Depierre, D Moro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 3, 2005
Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatinJ-L Pujol, J-L Breton, R Gervais, et al.
Pageof 19